ESC Premium Access

A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions

Topic: PCI / stents: devices and technique

Congress Presentation

About the speaker

Mr Emmanouil Brilakis

Minneapolis Heart Institute Foundation, Minneapolis (United States of America)
1 presentation
0 follower

6 more presentations in this session

Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome

Speaker: Doctor P. Tonino (Eindhoven, NL)


Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial

Speaker: Professor M. Hong (Seoul, KR)


Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus

Speaker: Doctor M. Holzmann (Stockholm, SE)


Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Speaker: Doctor M. Natsuaki (Saga, JP)


Clinical outcomes of State-of-the-Art percutaneous coronary revascularization in patients with de novo three vessel disease: Results of the SYNTAX II trial.

Speaker: Professor J. Escaned (Madrid, ES)


Access the full session

Late-Breaking Science in PCI 1

Speakers: Mr E. Brilakis, Doctor P. Tonino, Professor M. Hong, Doctor M. Holzmann, Doctor M. Natsuaki...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb